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iAbstract
Background: Veno-arterial extracorporeal membrane oxygenation (ECMO-CPR) is a
life-saving rescue for selected patients when standard cardiopulmonary resuscitation
fails. The use is increasing although the treatment modality is not fully established.
Resuscitated patients typically develop a detrimental early post-arrest cardiac dysfunction
that also deserves main emphasis. The present study investigates an ECMO-CPR strategy
in pigs and assesses early post-arrest left ventricular function in detail. We hypothesised
that a significant dysfunction could be demonstrated with this model using magnetic
resonance imaging (MRI), not previously used early post-arrest.
Methods: In eight anaesthetised pigs, a 15-min ventricular fibrillation was resuscitated
by an ECMO-CPR strategy of 150-min veno-arterial ECMO aiming at high blood flow rate
and pharmacologically sustained aortic blood pressure and pulse pressure of 50 and 15
mmHg, respectively. Pre-arrest cardiac MRI and haemodynamic measurements of left
ventricular function were compared to measurements performed 300-min post-arrest.
Results: All animals were successfully resuscitated, weaned from the ECMO circuit, and
haemodynamically stabilised post-arrest. Cardiac output was maintained by an increased
heart rate post-arrest, but left ventricular ejection fraction and stroke volume were
decreased by approximately 50 %. Systolic circumferential strain and mitral annular
plane systolic excursion as well as the left ventricular wall thickening were reduced
by approximately 50–70 % post-arrest. The diastolic function variables measured
were unchanged.
Conclusions: The present animal study demonstrates a successful ECMO-CPR
strategy resuscitating long-lasting cardiac arrest with adequate post-arrest
haemodynamic stability. The associated severe systolic left ventricular dysfunction
could be charted in detail by MRI, a valuable tool for future cardiac outcome
assessments in resuscitation research.
Trial registration: Institutional protocol number: FOTS 4611/13.
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Patients with cardiac arrest not responding to standard cardiopulmonary resuscitation
(CPR) can be resuscitated by veno-arterial extracorporeal membrane oxygenation
(ECMO-CPR). Advances in technology and equipment have made ECMO-CPR much
more attractive during recent years, and its use is increasing. The enthusiastic quest for
novel resuscitation techniques may be due to the fact that standard CPR frequently
fails. Although ECMO-CPR is claimed to represent “a frontier of resuscitation” [1], it is
not an established treatment modality. No controlled clinical ECMO-CPR studies exist,
but observational studies have been published [2–7]. Many centres have reported
positively on their clinical experiences as reviewed recently by Fagnoul et al. [8]. Studies
on ECMO-CPR usually focus on survival until hospital discharge and on post-arrest
neurological sequelae. End-points in experimental studies are frequently the regain of
spontaneous circulation (ROSC) and post-arrest brain tissue damage. A clinical
problem after ROSC, however, is the early post-arrest cardiac dysfunction with circula-
tory failure-increasing the risk of adverse neurological function and poor outcome in
resuscitated patients [9]. Detailed knowledge of cardiac function post-arrest is therefore
needed. Few data exist on cardiac dysfunction after ECMO-CPR. The purpose of the
present study was twofold; (1) to investigate ECMO-CPR in an experimental pig model
and (2) to assess the early post-arrest left ventricular (LV) function by cardiac magnetic
resonance imaging (MRI). We hypothesised that a significant early post-arrest LV
dysfunction could be demonstrated with this model using MRI. Cardiac MRI allows
accurate measurements of motions, volumes and flow in the beating heart and is not
previously used to describe early post-arrest cardiac dysfunction.Methods
Overall design and details
The study was a controlled experimental animal study. A listing of experiment details
is presented in Tables 1 and 2.Animal welfare
The experimental protocol was approved by the Norwegian National Animal Research
Authority. The animal experiments were performed in accordance with the European
Convention for the Protection of Vertebrate Animals used for Experimental and Other
Scientific Purposes (European Council, ETS No. 170). Personnel who handled the animals
were certified with Federation of Laboratory Animal Science Associations category C.
Detailed information according to the ARRIVE guidelines (Animals in Research: Reporting
In Vivo Experiments) [10] is presented in Additional file 1: Table S1. A pig model was
chosen because of the close similarities to human cardiac anatomy and physiology, also
adequate for the use of standard equipment and clinical MRI sequences.Animals and anaesthesia
Eight pigs were included in the study; each pig was kept fasting overnight-with free
access to water, pre-medicated in the pig box housing and weighted before a short
transport to the MRI research operating theatre. A mixture of intravenous anaesthesia
standardised by weight and suspended in Ringer’s acetate solution was infused at
Table 1 Animals and anaesthesia
Pig (sus scrofa domestica)
Strain Crossbreeding
Numbers included 8
Gender 3 female 5 male
Weight 49.7 ± 2.3 kg
Ventilation
Mode Volume control
Tidal volume 10 ml/kg
PEEP 5 cm H2O
Respiratory rate 18/min
I:E ratio 1:2
FiO2 40 %
Premedication (i.m)
Azaperone 4 ml 40mg/ml (3 mg/kg)
Ketamine 30 ml 50mg/ml (30 mg/kg)
Atropine 1 ml 1mg/ml (20 μg/kg)
Anaesthesia (i.v)
Pentobarbital 4 mg/kg/h
Morphine 2 mg/kg/h
Midazolam 0.15 mg/kg/h
Rocuronium 3 mg/kg/h
Euthansia (i.v)
Pentobarbital 20 ml 50 mg/ml (20 mg/kg)
Morphine 5 ml 10 mg/ml (1 mg/kg)
Potassium chloride 50 ml 1 mmol/ml (1 mmol/kg)
Animals and anaesthesia used in the experiments
Weight as mean ± standard deviation; PEEP positive end-expiratory pressure, I:E ratio the ratio of inspiratory time (I) to
expiratory time (E), FiO2 fraction of inspired oxygen, i.m. intra muscular, i.v. intra venous
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pinching or surgery and was chosen also to provide haemodynamic stability and
the safe use of neuromuscular blockade [11, 12].
Preparation
Each pig received a tracheostomy and intravascular catheters by a midline neck incision. A
micro-manometer pressure transducer was positioned in the LV via an 8 French vascular
introducer in the right carotid artery (Table 2). Both internal jugular veins were cannulated
with 9 French vascular introducers and used to place a pulmonary artery (PA) catheter and
a temporary pacing lead to the right ventricle. The femoral artery and the right external
jugular vein were cannulated with 14 French and 21 French ECMO cannulae, respectively,
using a guiding obturator placed over a guide-wire during fluoroscopy. To prevent ECMO
clotting, a bolus of intravenous heparin 2 mg/kg followed by infusion 0.5 mg/kg/h was
given to obtain an activated clotting time ≥300 s. Mechanical ventilation was set to keep
PaO2 within 20 ± 5 kPa and PaCO2 within 5.0 ± 0.5 kPa. Each pig had standard monitoring
during the experiment-including electrocardiography (ECG), pulse oximetry, end-tidal
expiratory CO2, hourly urine output and oesophageal temperature.
Table 2 Equipment
Accessories Name Company Location
Ventilator Leon Plus Heinen & Löwenstein Bad Ems Germany
Ventilator in MRI Fabius MRI Drägerwerk AG & Co Lübeck Germany
Left ventricle pressure
transducer
MPR-500 Millar Instruments Houston, TX USA
Venous vascular introducer AVA High-Flow
M3L9FHS 9Fr
Edwards Lifesciences Irvine, CA USA
Pulmonary artery catheter Swan-Ganz CCO Edwards Lifesciences Irvine, CA USA
Arterial vascular introducer Radifocusintroducer II
8Fr
Terumo Europe Leuven Belgium
Per venous pacing lead Qstim 5Fr VascoMed GmbH Binzen Germany
Pulmonary artery monitor Vigilance II Monitor Edwards Lifesciences Irvine, CA USA
Pressure transducer
software
Mikrosound Presenter
18.11.2011
Vestfold university
college
Tønsberg Norway
Defibrillator CodeMaster XL+ Hewlett Pachard Lexington, KY USA
Data analysis software Graphpad prism 6.04 GraphPad Software La Jolla, CA USA
Statistical software SPSS v.22 SPSS Chicago, IL USA
MRI Name Company Location
MRI Scanner w/software Philips Achieva 3 Tesla Philips Medical
Systems
DA Best Netherland
MRI tagging analysis software Diagnosoft HARP 3.0 Diagnosoft Durham, NC USA
MRI cine/phase-contrast
image analysis
Segment version 1.9
R2585
Medviso AB Lund Sweden
ECMO circuit Name Company Location
Cannulae Arterial: DLP Femoral
14Fr Venous: DLP
Jugular 21Fr
Medtronic Inc Minneapolis, MN USA
Centrifugal pump Biopump + BPX-80 Medtronic Inc Minneapolis, MN USA
Oxygenator Affinity NT Medtronic Inc Minneapolis, MN USA
Console Biomedicus 550
Bio-console
Medtronic Inc Minneapolis, MN USA
Flow transducer BioProbe TX50 Medtronic Inc Minneapolis, MN USA
Temperature probe Model TP Series
400 Thermistor Probe
Medtronic Inc Minneapolis, MN USA
Heat-exchanger Stöckert Heater-Cooler
System 3T
Sorin Group Milano Italy
Oxygen/air mixer Sechrist Model 20090 Sechrist Industries Anaheim, CA USA
Equipment used in the experiments
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Baseline assessments
After preparation and a following 30-min stabilisation period, baseline cardiac MRI and
haemodynamic measurements of LV function were obtained. An arterial and a mixed
venous blood sample were also analysed.
Establishment of ECMO
After baseline assessments, the pig was connected to a custom-made femoro-jugular
veno-arterial ECMO circuit (Table 2). The ECMO consisted of an 86 ml centrifugal
blood pump and a 270 ml micro-porous polypropylene hollow fibre oxygenator with a
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tion and sweep gas flow rate. The circuit was without surface coating and primed with
Ringer’s acetate solution. The machinery was initially set to standby with the vascular
lines clamped.
Cardiac arrest and resuscitation
Ventricular fibrillation (VF) was induced by an electrical stimulator connected to the
right ventricular pacing lead. VF was confirmed by ECG shape and aortic blood pres-
sure drop, and the ventilator was set to standby. After 15 min of untreated VF, ECMO-
CPR was initiated with initial blood pump speed at the maximum 4540 rounds per
minute. The sweep gas was set at the same flow rate as the ECMO blood flow rate, the
fraction of oxygen to 100 % and the circuit temperature to 38.0 °C (normothermia in
the pig). After 5 min of ECMO-CPR, fibrillation was terminated by external damped
sinusoidal waveform 360 Joule monofasic shocks through standard anterior/anterior
pads until sinus rhythm was obtained. The extracorporeal support continued at the
same blood flow rate for a total of 150 min. Repeated blood gas analyses were per-
formed, and the sweep gas flow rate and the oxygen/air mixture were adjusted accord-
ing to the protocol. The lowest acceptable mean aortic pressure (MAP) and pulse
pressure after defibrillation and regain of spontaneous cardiac beating (ROSB) was set
by protocol consensus to 50 and 15 mmHg, respectively. Intravenous adrenaline
(epinephrine) 10–25 μg boluses were given to ensure these criteria were met initially. If
in need of continued inotropic support, infusion of the beta-adrenergic agonist dobuta-
mine 5 μg/kg/min was started [13], and the infusion rate was adjusted if necessary.
Each pig was weaned from ECMO during a 60 min period with successive 0.7 l/min
reductions in blood flow rate every 10 min, to zero support. A 60-min stabilisation
period followed before post-arrest assessments.
Post-arrest assessments
At 285 min post-arrest, cardiac function was re-assessed by the PA catheter and the LV
pressure transducer. Arterial and mixed venous blood samples were analysed, and a
second cardiac MRI was made. Finally, the pig was euthanized.
Cardiac MRI measurements
Image acquisition, interpretation and post-processing were done according to the
recommendations from the Society for Cardiovascular Magnetic Resonance [14].
Cardiac MRI images were analysed by the software Segment version 1.9 R2585
(http://segment.heiberg.se) [15] and by Diagnosoft HARP 3.0.
The LV was assessed by adjacent parallel short-axis slices covering the full volume of
the LV and by long axis slices. Series of cinematographic images of the cardiac cycle
were recorded by retrospective ECG-gating without breath-holds. The images were
analysed to estimate end-diastolic volume (EDV), end-systolic volume (ESV),
stroke volume (SV = EDV-ESV), ejection fraction (EF = SV/EDV) and cardiac out-
put (CO = SV · heart rate (HR)). In addition, mid LV radial wall thickening and mi-
tral annular plane systolic excursion (MAPSE) were measured. Wall thickening
was averaged from measurements in the septum and the lateral wall, and MAPSE
averaged from antero-septal-and postero-lateral measurements.
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(tagging) to assess peak global systolic LV circumferential (Lagrangian) strain by har-
monic phase analysis [16]. Strain assessment provides information on the process of
myocardial deformation; it can be extended to include fine details [17], and it also
known to quantify myocardial function during echocardiography [18, 19].
Phase-contrast imaging with blood velocity encoded through-plane images of the
mid-ascending aorta was also included to assess LV stroke volume (SVphase) and cardiac
output (COphase). It has been stated that this technique “should provide the most
accurate measurement available of cardiac output” [20].
For further descriptions of cardiac MRI measurements the reader is kindly referred to
Additional files 2 and 3 with the accompanying illustrations in Additional file 4, 5, 6, 7 and 8.Haemodynamic measurements
The PA thermodilution CO measurements (COPA) were performed with injections
of 10-ml ice-cold isotonic glucose, and the COPA was calculated as the average
value of three consecutive measurements. Central venous pressure (CVP) was
measured, and the SV (SVPA = COPA/HR) and the systemic vascular resistance
(SVRPA = (MAP-CVP)/COPA∙80) were calculated.
The LV pressure transducer measurements were recorded on a separate PC
monitoring system and analysed offline with custom-built software based on a vis-
ual programming language (Table 2) [21]. The maximum systolic LV pressure
(LVPmax) and the maximum positive and negative first time derivate of LV pres-
sure (dP/dtmax and dP/dtmin) were measured, in addition to the end-diastolic LV
pressure (EDP) and the end-systolic LV pressure (ESP). Systolic duration was mea-
sured from ECG R-peak to dP/dtmin and diastolic duration from dP/dtmin to onset
of systole. Isovolumetric contraction time (IVC) was measured from ECG R-peak
to dP/dtmax. The isovolumetric relaxation constant tau was calculated using Weiss
method [22] in a 50-millisec time-frame starting at dP/dtmin. LV afterload was estimated
from arterial elastance (Ea = ESP/SV).Measurements of oxygen consumption and oxygen delivery
The arterial and venous oxygen content (CaO2 and CvO2) were calculated from the arter-
ial and mixed venous blood samples, respectively. Oxygen delivery (DO2 = CO∙CaO2) and
oxygen consumption (VO2 = CO∙arterio-venous oxygen difference (CaO2 -CvO2)) were
calculated.
Outside the MRI scanner continuous measurements of HR, MAP and mean pulmonary
artery pressure (MPAP) were recorded throughout the experiments (Fig. 1).Statistical analysis Statistical analyses of normality (D’Agostino-Pearson omnibus and
Shapiro-Wilk) and of equality of variances (Levenes) supported the use of parametric
tests. Data are reported as mean ± standard deviation if not otherwise stated. The statis-
tical significance level α was set to 0.05. A paired two-tailed t test was used to compare
baseline- and post-arrest measurements. The degree to which volumetrically and
phase-contrast estimates of SV change correlated was quantified by a Pearson’s correl-
ation analysis.
Fig. 1 Continuous haemodynamic measurements (outside the MRI scanner). Continuous HR (heart rate),
MAP (mean aortic pressure) and MPAP (mean pulmonary artery pressure) during the experiment, outside
MRI scanner, shown as mean values (black line) ± standard deviation (grey). Cardiac arrest (VF) was induced
at time 0 (bottom timeline, black triangle at dotted line). ECMO-CPR was started at time 15 (separate dotted line)
and defibrillation was done at time 20 (open triangle). ECMO continued for 150 min before a 60-min stepwise
weaning. Cardiac MRI of the beating heart was made ~60 min pre-arrest, and ~300 min post-arrest. The pig
was euthanized after the post-arrest cardiac MRI (bullet point)
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The pigs weighed 49.7 ± 2.3 kg, preparation took 119 ± 29 min and cardiac MRI scan
time was 63 ± 15 min. Prior to induction of cardiac arrest activated clotting time was
349 ± 83 s, and ECMO circuit priming volume was 538 ± 17 ml. The experiments lasted
747 ± 71 min.
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All animals were successfully defibrillated by a median of 1 shock (range 1–4). MAP
at the time of defibrillation was 52 ± 8 mmHg with an ECMO blood flow rate of
4.60 ± 0.15 l/min. VF spontaneously reemerged after ROSB in two pigs demanding
one additional defibrillation in both.Continuous haemodynamic measurements
Continuous HR, MAP and MPAP outside the MRI scanner are presented in Fig. 1. A
considerable leap in HR was observed immediately following the defibrillation. The HR
slowed gradually during the period of ECMO-CPR, but severe tachycardia with an
approximate frequency of 150 beats/min remained throughout the experiment. MAP
increased to a maximum of 77 ± 15 mmHg 2 min after defibrillation. MAP then
dropped over the next 13 min to a low point of 49 ± 9 mmHg 20 min after initiation of
ECMO-CPR. A further decrease in MAP was prevented by intravenous boluses of
adrenaline and infusion of dobutamine. The median total dose of dobutamine and
adrenaline was 10.3 mg (range 0–19.5 mg) and 80 μg (range 0–340 μg), respectively.
MPAP changed in parallel with MAP to a maximum of 20 ± 5 mmHg 2 min after defib-
rillation. Both pressures stabilised as adrenaline and dobutamine were added. During
the period of stepwise reductions in ECMO blood flow rate, MPAP increased in steps,
reaching 22 ± 4 mmHg when weaning was completed. All animals could be successfully
weaned from ECMO as dictated by the protocol. During the 60-min stabilisation period
following ECMO separation, the haemodynamics remained unchanged (Fig. 1).Baseline and post-arrest haemodynamic measurements and blood gas values
Haemodynamic measurements and blood gas values at baseline and post-arrest are pre-
sented in Table 3. The substantial increase in HR post-arrest limited the reductions in
CO. Systolic duration and isovolumetric contraction time were shortened by 33 ± 8 %
and 17 ± 12 %, respectively, whereas diastolic duration decreased by 57 ± 17 %. LV after-
load estimated by Ea increased post-arrest, and there was also a noticeable rise in
MPAP. There was a minor increase in dP/dtmax whereas LVPmax did not significantly
change; neither did EDP, dP/dtmin nor tau.
Arterial blood gas values remained virtually unaltered post-arrest, and the haemoglobin
concentration was stable (Table 3). The DO2 was maintained due to the increased HR, but
mixed venous oxygen saturation dropped from 69.4 ± 13.1 % to 44.0 ± 7.9 % (p < 0.001)
post-arrest, corresponding to a 66 ± 38 % increase in VO2 at almost unchanged DO2 (mean
difference –74 ml/min (p = 0.29)).Baseline and post-arrest cardiac MRI
Cardiac MRI measurements at baseline and at 308 min ± 8 min post-arrest are
presented in Table 4 and Fig. 2. LV function was severely reduced post-arrest, as EF
decreased from 61 ± 5 % to 34 ± 8 % (p < 0.001) and SV decreased from 62 ± 9 ml
to 30 ± 7 ml (p < 0.001). The lowered EF was related to a 58 ± 39 % increase in
ESV as EDV was maintained (mean difference −8.9 ml (p = 0.22)). The reduction
in SV was consistent with the change in SVphase (Pearson r = 0.7). The minor re-
duction in CO (0.5–0.7 l/min) was not statistically significant. Consistent with the
Table 3 Haemodynamic measurements and blood gas values
A. Pulmonary artery catheter measurements and MAP
Variable Baseline Post-arrest MD (95 % CI) p value
HRPA beats/min 86 ± 22 147 ± 28 61 ( 37 86) p < 0.001
MAP mmHg 84.3 ± 13.1 74.6 ± 16.8 −9.6 (−27.0 7.8) p = 0.23
COPA l/min 4.5 ± 0.6 3.8 ± 0.4 −0.72 (−1.5–0.08) p = 0.07
SVPA ml 53 ± 6 26 ± 3 −27 (−33–22) p < 0.001
MPAP mmHg 17.8 ± 3.6 23.6 ± 4.3 5.9 ( 3.4 8.4) p < 0.001
CVP mmHg 6.3 ± 2.6 6.3 ± 3.2 0.0 (−2.0 2.0) p = 1.0
Wedge mmHg 8.7 ± 3.7 8.5 ± 3.4 −0.2 (−3.4 3.1) p = 0.89
SVR dyne•s/cm−5 1390 ± 232 1438 ± 288 48 (−114 209) p = 0.51
B. Left ventricle pressure transducer measurements
Variable Baseline Post-arrest MD (95 % CI) p value
LVPmax mmHg 99.2 ± 7.1 91.4 ± 14.4 −7.9 (−23.4 7.6) p = 0.27
EDP mmHg 15.5 ± 4.0 14.7 ± 2.5 −0.8 (−5.4 3.9) p = 0.71
dP/dt max mmHg/sec 1440 ± 209.5 2034 ± 549.4 594.1 (15.3 1173) p = 0.046
dP/dtmin mmHg/sec −2086 ± 285 −1715 ± 419 371 ( −185 926) p = 0.16
tau msec 32.8 ± 3.0 33.5 ± 7.3 0.68 (−5.7 7.1) p = 0.68
Ea mmHg/ml 1.04 ± 0.21 1.67 ± 0.47 0.63 (0.21 1.06) p = 0.009
DD msec 440 ± 89 190 ± 40 −250 (−336–165) p < 0.001
SD msec 328 ± 19 220 ± 19 −109 ( −133–84) p < 0.001
IVC msec 50 ± 7 42 ± 6 −9 (−14–3) p = 0.007
C. Blood gas analyses
Variable Baseline Post-arrest MD (95 % CI) p value
Haemoglobin g/dl 8.4 ± 0.7 8.2 ± 0.8 −0.24 (−0.49 0.02) p = 0.06
PaO2 kPa 22.6 ± 2.1 20.1 ± 3.5 −2.5 (−4.7–0.34) p = 0.03
PaCO2 kPa 5.2 ± 0.4 5.3 ± 0.3 0.14 (−0.29 0.57) p = 0.46
pH 7.50 ± 0.03 7.47 ± 0.04 −0.03 (−0.07 0.01) p = 0.08
Base excess mmol/l 6.63 ± 1.25 4.73 ± 1.79 −1.9 (−3.02–0.78) p = 0.005
Lactate mmol/l 0.88 ± 0.21 1.34 ± 0.54 0.46 (−0.03 0.95) p = 0.06
Ca2+ mmol/l 1.29 ± 0.07 1.26 ± 0.07 −0.025 (−0.08 0.03) p = 0.32
SvO2 % 69.4 ± 13.1 44.0 ± 7.9 −25.4 (−36.4–14.4) p < 0.001
DO2 ml/min 572 ± 124 499 ± 119 −74 (−228 79) p = 0.29
VO2 ml/min 164 ± 49 273 ± 46 109 (57 160) p = 0.002
HRPA, COPA and SVPA pulmonary artery catheter assessments of heart rate, cardiac output and stroke volume, MAP mean
aortic pressure, CVP central venous pressure, Wedge pulmonary arterial wedge pressure, SVR systemic vascular resistance,
LVPmax systolic left ventricular pressure maximum, EDP end-diastolic pressure, dP/dtmax and dP/dtmin maximum and minimum
LVP time derivates, tau isovolumetric relaxation constant, Ea arterial elastance, DD diastolic duration, SD systolic duration,
IVC isovolumetric contraction time, SVO2 mixed venous oxygen saturation, DO2 oxygen delivery, VO2 oxygen consumption
Values are expressed as mean ± standard deviation. MD mean difference, CI confidence interval, significance
level p ≤ 0.05
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from −17.4 ± 4.2 % to −5.1 ± 3.3 % (p < 0.001) and MAPSE was reduced from 12 ± 1 mm
to 6 ± 1 mm (p <0.001). Similarly, mid LV radial wall thickening was severely af-
fected by a reduction from 58 ± 18 % to 20 ± 9 % (p < 0.001). The reductions in
MAPSE and wall thickening were consistent between the different measuring loca-
tions in the LV.
Table 4 Cardiac MRI measurements
Variable Baseline Post-arrest MD (95 % CI) p value
HRMRI beats/min 83 ± 19 153 ± 32 70 (36 103) p = 0.002
COphase l/min 4.5 ± 0.6 3.8 ± 0.9 −0.7 (−1.7 0.3) p = 0.12
SVphase ml 56 ± 9 26 ± 9 −29 (−41–18) p < 0.001
EDV ml 100 ± 10 92 ± 15 −8.9 (−25 7) p = 0.22
ESV ml 39 ± 5 61 ± 15 23 (10 35) p = 0.003
Wall thickening septum % 56 ± 18 17 ± 11 −39 (−53–25) p < 0.001
Wall thickening lat % 59 ± 31 22 ± 10 −37 (−65–9) p = 0.016
MAPSEantsept mm 10 ± 2 4 ± 1 −6 (−7 -4) p < 0.001
MAPSEpostlat mm 15 ± 1 8 ± 2 −7 (−9 -5) p < 0.001
HRMRI heart rate during MRI, COphase and SVphase cardiac output and stroke volume by cardiac MRI phase-contrast technique,
EDV end-diastolic volume, ESV end-systolic volume, Wall thickening septum and Wall thickening lat mid left ventricular radial wall
thickening in septum and lateral wall, MAPSEantsept and MAPSEpostlat mitral annular plane systolic excursion measured
anteroseptally and posterolaterally
Values are expressed as mean ± standard deviation. MD mean difference, CI confidence interval; significance level p ≤ 0.05
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In this study, ECMO-CPR emerged as an effective tool resuscitating the heart from
long-lasting cardiac arrest. Fifteen minutes of VF induced a severe early post-arrest LV
dysfunction that was demonstrated in detail by cardiac MRI. This is the first study to
describe early post-arrest LV dysfunction by cardiac MRI.
There are no ECMO-CPR guidelines for patients with refractory cardiac arrest. As a
consequence, several strategies are implemented targeting various circuit flows, arterial
pressures, oxygen saturations and core temperatures. Indications may also differ
between centres, although a refractory normothermic arrest with a no-flow period ofFig. 2 Baseline and post-arrest cardiac MRI. EF (ejection fraction), SV (stroke volume), CO (cardiac output),
MAPSE (mitral annular plane systolic excursion), strain (peak global systolic left ventricular circumferential
strain) and wall thickening before (baseline) and at ~300 min post-arrest. A paired two-tailed t test was used
to compare baseline- and post-arrest measurements; asterisk: p value < 0.001
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often stated as the clinical accepted limit of low-flow (the period of standard CPR) be-
fore ECMO is established. In animals, without extracorporeal support the probability of
successful ROSC decreases drastically when VF is untreated for more than 10–12 min,
and it is almost impossible to achieve sustainable ROSC in pigs after 15 min of
untreated VF [23–26]. In the present study, the 15 min duration of cardiac arrest
followed by ECMO-CPR was chosen to allow early survival [23, 27–30], but with a sig-
nificant post-arrest cardiac dysfunction that could be examined by cardiac MRI in a
stable state.
ECMO-CPR strategy
All pigs were successfully resuscitated by our protocol using a short (150 min) ECMO-
CPR run with maximal flow, initially 100 % oxygen, normothermia, MAP above 50
mmHg and pulse pressure above 15 mmHg. The diameter, length and position of the
venous cannula usually limit the ECMO blood flow rate. In our study, the venous can-
nula was placed as deep as the diaphragm, with its multiple side holes covering the full
length of the caval veins and the right atrium. With this placement, the ECMO blood
flow rate during ECMO-CPR could be kept as high as baseline CO pre-arrest without
incidents of “suck down”, and increased CVP could be avoided. The low MPAP during
ECMO-CPR indicated a relatively low blood flow through the pulmonary circulation,
and thus a limited amount of blood entering the LV. This venous unloading, combined
with adequate myocardial perfusion, is known to be particularly important to the post-
arrest myocardium [31].
In peripheral veno-arterial ECMO, blood from the arterial cannula flows upwards in
the descending aorta, increasing LV afterload. LV distension may then develop with
compromised myocardial perfusion and hydrostatic pulmonary oedema. Although cor-
onary perfusion was not measured, serious hypo-perfusion was most likely prevented
by our protocol with the attention to adequate MAP and pulse pressure, the latter to
assure LV emptying. The pressures were maintained above the lower limits by the cus-
tomised dosage of positive inotropic medication. Dobutamine enhance LV function
post-arrest [32]. All pigs could be weaned from extracorporeal support in accordance
with the study protocol—this success would not have been possible after ECMO-CPR
with severely compromised myocardial perfusion.
LV function after ECMO-CPR
Cardiac MRI is often considered as the reference standard for the assessments of LV
volumes and function. In addition, we assessed post-arrest LV haemodynamics by a PA
catheter and a LV pressure transducer. Cardiac MRI demonstrated a severe impairment
of LV function after ECMO-CPR. The systolic dysfunction was evident both by the glo-
bal volume and flow measurements and by the LV motion measurements, mid LV
radial wall thickening, MAPSE, and global systolic circumferential strain. Interestingly,
post-arrest dysfunction was characterised by almost similar reductions (approximately
50–70 %) of systolic LV motion in all three deformation directions, indicating a global
LV impairment.
When compared to cardiac MRI the LVP and dP/dt measurements did not re-
flect the severity of systolic LV dysfunction. LVP was maintained because MAP
Bergan et al. Intensive Care Medicine Experimental  (2015) 3:25 Page 12 of 15was pharmacologically sustained as prescribed by the protocol. An increased ino-
tropic state post-arrest-a result of the dobutamine infusion and an endogenous
catecholamine response [33, 34] probably contributed to the observed increase in
dP/dtmax and HR [35, 36]. In addition, an increased afterload (Ea) post-arrest and
a shorter systolic duration and IVC may also have influenced the dP/dt variable
[37, 38]. The COPA and SVPA measurements, however, corresponded well with the
MRI measurements, but PA assessments gave less information.
In addition to the success of ECMO-CPR, our study demonstrates that a detailed
assessment of early post-arrest LV dysfunction is feasible by cardiac MRI. The model
may be relevant for future research on ECMO-CPR strategies and cardiac outcome.
Diastolic LV dysfunction was not demonstrated by the LV function variables included
in this study. Post-arrest ESV increased without changes in EDV or EDP, indicating
reduced systolic emptying of a ventricle adequately filled in diastole. A preserved dia-
stolic function was supported by an unaltered tau and dP/dtmin post-arrest, indicating
normal LV relaxation. Taken together, this can imply that LV dysfunction after ECMO-
CPR is a failure of myocardial contractile function, not predominantly related to LV re-
laxation ability. Increased HR and dP/dtmax with reduced SV, and preserved diastolic
function with maintained dP/dtmin, tau, and end-diastolic pressure-volume relationship
have also been demonstrated after hypoxic cardiac arrest in pigs [27]. Early post-arrest
LV dysfunction in pre-arrest healthy hearts thus seems similar whether cardiac arrest is
induced electrically or by hypoxia.
The reduced SV post-arrest was compensated for by an increased HR, maintaining
CO and DO2. However, the substantial drop in mixed venous oxygen saturation indi-
cates that DO2 was insufficient for the increased post-arrest metabolic needs. The
increased VO2 may be due to recovery from oxygen debt and activation of other
oxygen consuming processes such as systemic inflammation, induced by ischemia
and reperfusion [39].
Limitations
Our experimental model was different from a clinical ECMO-CPR scenario. In our
study, healthy pigs were included, and cardiac arrest was introduced electrically. The
duration of no-flow-exceeding usual clinical limits was intended to achieve a combin-
ation of survival and a certainly measurable post-arrest cardiac dysfunction. Cardiovas-
cular function was in focus, and no attention was paid to neurological or other organ
outcome. Pre-arrest heparinisation is a common experimental approach that also differs
from the later on (or omitted) clinical heparin administration. Sham-operated animals
were decided not included as the experiments were completed without complications,
haemodynamic stability was adequate (Fig. 1), and veno-arterial ECMO only does not
seem to affect intrinsic function of the porcine heart [40]. The reversibility of post-arrest
myocardial LV dysfunction (stunning) was not addressed as it may take several days for the
heart to fully recover. Some myocardial necrosis cannot be excluded, encouraging future
investigations of myocardial damage related to ECMO-CPR in this model.
Conclusions
An ECMO-CPR strategy of 150-min veno-arterial ECMO aiming at high blood flow
rate and pharmacologically sustained aortic blood pressure and pulse pressure allowed
Bergan et al. Intensive Care Medicine Experimental  (2015) 3:25 Page 13 of 15successful resuscitation of long-lasting cardiac arrest with adequate post-arrest haemo-
dynamic stability in pigs. MRI imaging of the in vivo beating heart demonstrated a
severe early post-arrest LV dysfunction. Systolic LV function variables were substantially
reduced whereas diastolic function was preserved. Cardiac MRI will be a valuable tool
for future research on post-arrest cardiac dysfunction including assessment of cardiac
outcome after ECMO-CPR.
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